Live Breaking News & Updates on Centera Bio

Stay updated with breaking news from Centera bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU - AbbVie (NYSE:ABBV), ALX Oncology Holdings (NASDAQ:ALXO)

AbbVie (NYSE: ABBV) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of Skyrizi (risankizumab) in the EU to treat adults with moderately to severely active ulcerative colitis (UC). ....

United States , Abbvie Skyrizi , Annovis Bio , Boehringer Ingelheim , Abbvie Inc , Committee For Medicinal Products Human Use , Entera Bio Ltd , European Medicines Agency , Oncology Holdings , Medicinal Products , Human Use , Zacks Rank , Centera Bio , Zacks Consensus Estimate ,